—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Hims Hers Health Inc (HIMS) — the peer cohort

As of 2026-11-13 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

Hims Hers Health Inc ranks 7 of 7 in its cohort on the Closelooknet composite (36/100) — the cohort is led by Laboratorios Farmaceuticos ROVI at 64/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
HIMS Hims Hers Health Inc 36 27 30 22 info 51.9%
ROVI.MC Laboratorios Farmaceuticos ROVI 64 62 77 47 info 18.8%
LNTH Lantheus Holdings Inc 59 70 73 53 ok 9.2%
IRWD Ironwood Pharmaceuticals Inc 58 73 77 83 info 16.4%
KNSA Kiniksa Pharmaceuticals Ltd 58 95 61 17 ok 3%
GALDY GALDERMA GROUP AG 57 73 59 21 ok 4.5%
ALM.MC Almirall S.A. 55 44 46 65 info 22.6%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-11-13

Quick answers

Who are Hims Hers Health Inc's peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: Laboratorios Farmaceuticos ROVI (ROVI.MC), Lantheus Holdings Inc (LNTH), Ironwood Pharmaceuticals Inc (IRWD), Kiniksa Pharmaceuticals Ltd (KNSA), GALDERMA GROUP AG (GALDY), Almirall S.A. (ALM.MC), as of 2026-11-13.

How does HIMS score against its peers?

Hims Hers Health Inc's composite reads 36/100, ranking 7 of 7 in its cohort as of 2026-11-13; the cohort's highest composite is Laboratorios Farmaceuticos ROVI at 64/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.